Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).

Clinical trial NCT00665314 · COMPLETED

Trial details

NCT number: NCT00665314
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Non Hodgkin's Lymphoma Hodgkin's Disease Multiple Myeloma

Start date: 2007-11-01
Primary completion: 2008-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.